Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004017375 | SCV004849039 | uncertain significance | Cardiovascular phenotype | 2017-08-17 | criteria provided, single submitter | clinical testing | The c.921G>A (p.M307I) alteration is located in exon 2 (coding exon 1) of the KCNJ2 gene. This alteration results from a G to A substitution at nucleotide position 921, causing the methionine (M) at amino acid position 307 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Cardiovascular Biomedical Research Unit, |
RCV000058337 | SCV000089857 | not provided | Congenital long QT syndrome | no assertion provided | literature only | This variant has been reported in the following publications (PMID:17211524). |